TAVI: Direct Flow to put its valve up against Medtronic's CoreValve – MassDevice

Direct Flow Medical said today that it won FDA approval to add a head-to-head comparison with Medtronic‘s (NYSE:MDT) CoreValve device to a clinical trial of its replacement heart valve.